AMP Practice Guidelines
Collapse Interpretation and Reporting of Sequence Variants — Inherited Conditions (CE available)

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

The webinar covers the development of the publication "AMP/ACMG Standards and Guidelines for the Interpretation of Sequence Variants". Attendees will learn how to apply the guidelines to classify individual sequence variants.


Practice Guideline Available Here

Speaker: Elaine B. Spector, PhD, FACMG

Host: Kristy Crooks, PhD

Duration: 1 hr

Level of Instruction: Basic

If you would like continuing education credit, click on the links below.

Credit Type

Number of Credit Hours

Click on link to purchase:

CME/CMLE

1.0

Purchase webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM

1.0

Purchase webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by June 29, 2020.

 

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Streaming
Original Course Date: June 29, 2017
MORE INFOMORE INFO Interpretation and Reporting of Sequence Variants — Inherited Conditions (CE available)
Collapse Molecular Biomarkers for the Evaluation of Colorectal Cancer (CE available)

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

In this webinar, Antonia Sepulveda provides an overview of the American Society of Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO)'s evidence-based practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.

The guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer which aids in establishing standard molecular marker testing to help guide targeted therapy decisions and advance personalized care for colorectal cancer patients.


Practice Guideline Available Here

Speaker: Antonia R. Sepulveda MD, PhD

Duration: 1.0 hr

Level of Instruction: Basic

If you would like continuing education credit, click on the links below.

Credit Type

Number of Credit Hours

Click on link to purchase:

CME/CMLE

1.0

Purchase webinar + CME/CMLE

(Just $5.00 USD for AMP members)

SAM

1.0

Purchase webinar + SAM

(Just $10.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by March 31, 2020

 

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Streaming
Original Course Date: March 31, 2017
MORE INFOMORE INFO Molecular Biomarkers for the Evaluation of Colorectal Cancer (CE available)
Collapse The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer

Recent definitions for clinical utility of molecular tests focus on whether a test result will alter treatment. This definition neglects other uses of molecular testing to diagnose disease, manage symptoms, prognosticate or predict future disease. The fullest realization of precision medicine will require embracing all aspects of clinical utility. This three-part webinar series, supported by AMP, presents the discussions of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility (FEND) working group, and its resulting publication, “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology” (Joseph L, et al. J Mol Diagn. 2016;18[5]:605–619).

 

Part 1 - An Overview of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility

Speakers: Loren Joseph, MD; Elaine Lyon, PhD

Host: Roger Klein, MD, JD

 

Part 2 - AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Oncology Cases

Speakers: Pranil Chandra, DO, FCAP, FASP; Rajyasree Emmadi, MD, FCAP

Host: Loren Joseph, MD

 

Part 3: AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Inherited Conditions

Speakers: Stephanie Hallam, PhD, FACMG, MBA; Victoria Pratt, PhD, FACMG

Host: Elaine Lyon, PhD

Practice Guideline Available Here

Total Duration: 3 hr

 

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

Formats Available: Streaming
Original Course Date: September 28, 2016
MORE INFOMORE INFO The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer